Global At-Home Cancer Testing Market Overview:
Global At-Home Cancer Testing Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global At-Home Cancer Testing Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of At-Home Cancer Testing involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the At-Home Cancer Testing Market:
The At-Home Cancer Testing Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for At-Home Cancer Testing Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study At-Home Cancer Testing Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, At-Home Cancer Testing market has been segmented into:
Genetic Testing
Biomarker Testing
Immunological Testing
Cell-free DNA Testing
By Application, At-Home Cancer Testing market has been segmented into:
Blood Sample
Saliva Sample
Urine Sample
Tissue Sample
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The At-Home Cancer Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the At-Home Cancer Testing market.
Top Key Players Covered in At-Home Cancer Testing market are:
23andMe
PathAI
Guardant Health
Egenomics
Quanterix
NantHealth
Oncocyte
Genomic Health
Exact Sciences
Myriad Genetics
Freenome
Invitae
CancerIQ
GRAIL
Thermo Fisher Scientific
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: At-Home Cancer Testing Market Type
4.1 At-Home Cancer Testing Market Snapshot and Growth Engine
4.2 At-Home Cancer Testing Market Overview
4.3 Genetic Testing
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Genetic Testing: Geographic Segmentation Analysis
4.4 Biomarker Testing
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Biomarker Testing: Geographic Segmentation Analysis
4.5 Immunological Testing
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Immunological Testing: Geographic Segmentation Analysis
4.6 Cell-free DNA Testing
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.6.3 Cell-free DNA Testing: Geographic Segmentation Analysis
Chapter 5: At-Home Cancer Testing Market Application
5.1 At-Home Cancer Testing Market Snapshot and Growth Engine
5.2 At-Home Cancer Testing Market Overview
5.3 Blood Sample
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Blood Sample: Geographic Segmentation Analysis
5.4 Saliva Sample
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Saliva Sample: Geographic Segmentation Analysis
5.5 Urine Sample
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Urine Sample: Geographic Segmentation Analysis
5.6 Tissue Sample
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 Tissue Sample: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 At-Home Cancer Testing Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 23ANDME
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 PATHAI
6.4 GUARDANT HEALTH
6.5 EGENOMICS
6.6 QUANTERIX
6.7 NANTHEALTH
6.8 ONCOCYTE
6.9 GENOMIC HEALTH
6.10 EXACT SCIENCES
6.11 MYRIAD GENETICS
6.12 FREENOME
6.13 INVITAE
6.14 CANCERIQ
6.15 GRAIL
6.16 THERMO FISHER SCIENTIFIC
Chapter 7: Global At-Home Cancer Testing Market By Region
7.1 Overview
7.2. North America At-Home Cancer Testing Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Genetic Testing
7.2.2.2 Biomarker Testing
7.2.2.3 Immunological Testing
7.2.2.4 Cell-free DNA Testing
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Blood Sample
7.2.3.2 Saliva Sample
7.2.3.3 Urine Sample
7.2.3.4 Tissue Sample
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe At-Home Cancer Testing Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Genetic Testing
7.3.2.2 Biomarker Testing
7.3.2.3 Immunological Testing
7.3.2.4 Cell-free DNA Testing
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Blood Sample
7.3.3.2 Saliva Sample
7.3.3.3 Urine Sample
7.3.3.4 Tissue Sample
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe At-Home Cancer Testing Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Genetic Testing
7.4.2.2 Biomarker Testing
7.4.2.3 Immunological Testing
7.4.2.4 Cell-free DNA Testing
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Blood Sample
7.4.3.2 Saliva Sample
7.4.3.3 Urine Sample
7.4.3.4 Tissue Sample
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific At-Home Cancer Testing Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Genetic Testing
7.5.2.2 Biomarker Testing
7.5.2.3 Immunological Testing
7.5.2.4 Cell-free DNA Testing
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Blood Sample
7.5.3.2 Saliva Sample
7.5.3.3 Urine Sample
7.5.3.4 Tissue Sample
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa At-Home Cancer Testing Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Genetic Testing
7.6.2.2 Biomarker Testing
7.6.2.3 Immunological Testing
7.6.2.4 Cell-free DNA Testing
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Blood Sample
7.6.3.2 Saliva Sample
7.6.3.3 Urine Sample
7.6.3.4 Tissue Sample
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America At-Home Cancer Testing Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Genetic Testing
7.7.2.2 Biomarker Testing
7.7.2.3 Immunological Testing
7.7.2.4 Cell-free DNA Testing
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Blood Sample
7.7.3.2 Saliva Sample
7.7.3.3 Urine Sample
7.7.3.4 Tissue Sample
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
At-Home Cancer Testing Scope:
|
Report Data
|
At-Home Cancer Testing Market
|
|
At-Home Cancer Testing Market Size in 2025
|
USD XX million
|
|
At-Home Cancer Testing CAGR 2025 - 2032
|
XX%
|
|
At-Home Cancer Testing Base Year
|
2024
|
|
At-Home Cancer Testing Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
23andMe, PathAI, Guardant Health, Egenomics, Quanterix, NantHealth, Oncocyte, Genomic Health, Exact Sciences, Myriad Genetics, Freenome, Invitae, CancerIQ, GRAIL, Thermo Fisher Scientific.
|
|
Key Segments
|
By Type
Genetic Testing
Biomarker Testing
Immunological Testing
Cell-free DNA Testing
By Applications
Blood Sample
Saliva Sample
Urine Sample
Tissue Sample
|
